J, L., K, S., M, S., A, H., LZ, Y., A, E., . . . JH, L. (2026). Impact of 25% Albumin on Vasopressor Requirements in Critically Ill Patients Receiving Continuous Renal Replacement Therapy. The Annals of pharmacotherapy, 60(7), 642. https://doi.org/10.1177/10600280251384651
Chicago Style (17th ed.) CitationJ, Lessing, Stilley K, Sharpe M, Howard A, Yang LZ, Erkanli A, Vatsaas C, Gilstrap D, and Levy JH. "Impact of 25% Albumin on Vasopressor Requirements in Critically Ill Patients Receiving Continuous Renal Replacement Therapy." The Annals of Pharmacotherapy 60, no. 7 (2026): 642. https://doi.org/10.1177/10600280251384651.
MLA (9th ed.) CitationJ, Lessing, et al. "Impact of 25% Albumin on Vasopressor Requirements in Critically Ill Patients Receiving Continuous Renal Replacement Therapy." The Annals of Pharmacotherapy, vol. 60, no. 7, 2026, p. 642, https://doi.org/10.1177/10600280251384651.